Active, Not Recruiting
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
NCT07196774
- Conditions
- Early-stage or Locally Advanced HER2-positive Breast Cancer
- Locations
-
- Shengjing Hospital, China Medical University Shenyang, Liaoning, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China